Exact Sciences Corp
EXASDelisted Mar 23, 2026- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001124140
Exact Sciences Corp was delisted on Mar 23, 2026; its insiders filed their last Form 4 on Mar 23, 2026; 715 institutions reported holding it in 13F filings for Q4 2025, worth $17.9B in total; superinvestors Soros Fund Management and ARK Invest held it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 12:29 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $207.9M (6.4% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 13, 2026 | Jan 13, 2025 | Jan 8, 2024 | Jan 9, 2023 | Jan 10, 2022 |
| Revenue | $3.25B | $2.76B | $2.50B | $2.08B | $1.77B |
| Cost of revenue | $984.2M | $840.1M | $654.2M | $574.4M | $458.8M |
| Gross profit | $2.26B | $1.92B | – | – | – |
| Operating expenses | $2.47B | $2.98B | – | – | – |
| Research and development | $523.0M | $431.2M | $425.9M | $393.4M | $385.6M |
| Selling, general and administrative | $888.7M | $781.8M | $893.2M | $737.3M | $801.3M |
| Operating income | -$206.3M | -$1.05B | -$215.0M | -$593.5M | -$855.7M |
| Interest expense | $32.9M | $22.3M | $19.4M | $19.6M | $18.6M |
| Income tax | $4.06M | -$7.30M | $2.40M | -$9.06M | -$246.9M |
| Net income | -$207.9M | -$1.03B | -$204.1M | -$623.5M | -$595.6M |
| EPS, basic | $-1.10 | $-5.59 | $-1.13 | $-3.54 | $-3.48 |
| EPS, diluted | $-1.10 | $-5.59 | $-1.13 | $-3.54 | $-3.48 |
| Weighted shares, basic | 188.7M | 184.2M | 180.1M | 176.4M | 171.3M |
| Weighted shares, diluted | 188.7M | 184.2M | 180.1M | 176.4M | 171.3M |
| Margins and growth | |||||
| Gross margin | 69.7% | 69.5% | – | – | – |
| Operating margin | -6.4% | -38.0% | -8.6% | -28.5% | -48.4% |
| Net margin | -6.4% | -37.3% | -8.2% | -29.9% | -33.7% |
| Revenue growth, year over year | +17.7% | +10.4% | +19.9% | +17.9% | +18.5% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 13, 2026 | Jan 13, 2025 | Jan 8, 2024 | Jan 9, 2023 | Jan 10, 2022 |
| Cash and equivalents | $956.0M | $600.9M | $605.4M | $242.5M | $315.5M |
| Short-term investments | $8.71M | $437.1M | $172.3M | $389.6M | $715.0M |
| Accounts receivable | $298.7M | $249.0M | $203.6M | $158.0M | $216.6M |
| Inventory | $166.2M | $162.4M | $127.5M | $118.3M | $105.0M |
| Total current assets | $1.56B | $1.57B | $1.19B | $982.3M | $1.43B |
| Property, plant and equipment | $708.7M | $693.7M | $698.4M | $684.8M | $580.2M |
| Goodwill | $2.37B | $2.37B | $2.37B | $2.35B | $2.34B |
| Intangible assets | $919.9M | $1.01B | $1.89B | $1.96B | $2.09B |
| Total assets | $5.86B | $5.93B | $6.47B | $6.23B | $6.68B |
| Accounts payable | $175.9M | $89.6M | $78.8M | $74.9M | $67.8M |
| Total current liabilities | $641.2M | $732.2M | $514.7M | $412.7M | $517.1M |
| Total liabilities | $3.46B | $3.53B | $3.33B | $3.18B | $3.30B |
| Shareholders' equity | $2.40B | $2.40B | $3.15B | $3.04B | $3.39B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 13, 2026 | Jan 13, 2025 | Jan 8, 2024 | Jan 9, 2023 | Jan 10, 2022 |
| Operating cash flow | $491.4M | $210.5M | $156.1M | -$223.6M | -$102.2M |
| Capital expenditures | $134.7M | $136.0M | $124.2M | $214.5M | $135.8M |
| Free cash flow | $356.8M | $74.5M | $31.9M | -$438.0M | -$238.0M |
| Stock-based compensation | $217.7M | $214.9M | $231.3M | $206.8M | $253.1M |
| Investing cash flow | $195.1M | -$442.2M | $49.7M | $74.1M | -$1.08B |
| Financing cash flow | -$338.1M | $231.9M | $159.8M | $76.5M | $8.47M |
| Net change in cash | $349.4M | -$3.04M | $366.9M | -$73.0M | -$1.18B |
| Ratio | |||||
| Stock-based compensation, % of revenue | 6.7% | 7.8% | 9.3% | 9.9% | 14.3% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Feb 12, 2026 | 190.9M | +2.8% | SEC |
| Oct 31, 2025 | 189.5M | +2.4% | SEC |
| Aug 5, 2025 | 189.3M | +2.5% | SEC |
| Apr 30, 2025 | 188.6M | +2.2% | SEC |
| Feb 18, 2025 | 185.8M | +2.3% | SEC |
| Nov 4, 2024 | 185.1M | +2.3% | SEC |
| Jul 30, 2024 | 184.8M | +2.3% | SEC |
| May 7, 2024 | 184.5M | +2.3% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.